Shares of Nephrocare Health Services Ltd, the parent of the NephroPlus dialysis services chain, made a strong debut on the stock exchanges on Wednesday, listing at a premium of around 6.9 % over their IPO price of ₹460 per share on the Bombay Stock Exchange (BSE).
Chinese artificial intelligence chip startup Biren Technology is planning to launch its initial public offering (IPO) on the Hong Kong Stock Exchange within the coming weeks, according to people familiar with the matter. The offering is expected to raise around $300 million, reflecting investor interest in China’s booming AI semiconductor market.
Corona Remedies, a pharmaceutical company, saw its shares list at a 38% premium over the IPO price on the National Stock Exchange (NSE). The strong listing reflects robust investor demand and market enthusiasm for pharmaceutical stocks amid ongoing healthcare needs.
Regulator SEBI is re-examining the mutual fund fee structure with a focus on improving cost efficiency for investors, a move that also aligns with broader reforms linked to IPO disclosures and market transparency. The proposal is expected to be discussed at an upcoming SEBI board meeting.
ICICI Prudential Life Insurance stock has shown a bullish technical breakout from an ascending triangle pattern, making it an attractive trading opportunity for short-term investors.
Meesho, one of India’s fastest-growing e-commerce startups, has often been described as the “Aam Aadmi’s Amazon” because of its focus on affordable products and deep reach into tier-2, tier-3 and smaller Indian cities.
In what is being called a record-breaking IPO “gold rush”, promoters, private-equity funds and early-stage backers of Indian companies have sold shares worth more than ₹1 lakh crore through Offer-for-Sale (OFS) routes during 2025 — the highest ever in the country’s stock-market history.
The IPO of Western Overseas Study Abroad is listing today on the BSE SME platform.
KSH International is set to launch an initial public offering (IPO) worth ₹710 crore, with the issue opening for subscription on December 18, 2025.
What the Markets & Experts Are Saying (Pre-Listing)
According to reports, Meesho shows the strongest investor interest going into listing: grey-market premium (GMP) around 38%–40%, suggesting strong expected listing gains.
For those of you who are serious about having more, doing more, giving more and being more, success is achievable with some understanding of what to do.
